P2 receptors in atherosclerosis and postangioplasty restenosis

Cheikh Seye, Qiongman Kong, Ningpu Yu, Fernando A. Gonzalez, Laurie Erb, Gary A. Weisman

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Atherosclerosis is an immunoinflammatory process that involves complex interactions between the vessel wall and blood components and is thought to be initiated by endothelial dysfunction [Ross (Nature 362:801-809, 1993); Fuster et al. (N Engl J Med 326:242-250, 1992); Davies and Woolf (Br Heart J 69:S3-S11, 1993)]. Extracellular nucleotides that are released from a variety of arterial and blood cells [Di Virgilio and Solini (Br J Pharmacol 135:831-842, 2002)] can bind to P2 receptors and modulate proliferation and migration of smooth muscle cells (SMC), which are known to be involved in intimal hyperplasia that accompanies atherosclerosis and postangioplasty restenosis [Lafont et al. (Circ Res 76:996-1002, 1995)]. In addition, P2 receptors mediate many other functions including platelet aggregation, leukocyte adherence, and arterial vasomotricity. A direct pathological role of P2 receptors is reinforced by recent evidence showing that upregulation and activation of P2Y2 receptors in rabbit arteries mediates intimal hyperplasia [Seye et al. (Circulation 106:2720-2726, 2002)]. In addition, upregulation of functional P2Y receptors also has been demonstrated in the basilar artery of the rat double-hemorrhage model [Carpenter et al. (Stroke 32:516-522, 2001)] and in coronary artery of diabetic dyslipidemic pigs [Hill et al. (J Vasc Res 38:432-443, 2001)]. It has been proposed that upregulation of P2Y receptors may be a potential diagnostic indicator for the early stages of atherosclerosis [Elmaleh et al. (Proc Natl Acad Sci U S A 95:691-695, 1998)]. Therefore, particular effort must be made to understand the consequences of nucleotide release from cells in the cardiovascular system and the subsequent effects of P2 nucleotide receptor activation in blood vessels, which may reveal novel therapeutic strategies for atherosclerosis and restenosis after angioplasty.

Original languageEnglish (US)
Pages (from-to)153-162
Number of pages10
JournalPurinergic Signalling
Volume3
Issue number1-2
DOIs
StatePublished - Mar 2007
Externally publishedYes

Fingerprint

Atherosclerosis
Tunica Intima
Up-Regulation
Nucleotides
Hyperplasia
Blood Vessels
Purinergic P2Y2 Receptors
Basilar Artery
Cardiovascular System
Platelet Aggregation
Angioplasty
Smooth Muscle Myocytes
Blood Cells
Coronary Vessels
Leukocytes
Swine
Arteries
Stroke
Hemorrhage
Rabbits

Keywords

  • Atherosclerosis
  • Inflammation
  • Migration
  • Nucleotide receptors
  • Proliferation
  • Restenosis
  • Smooth muscle cell

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Cellular and Molecular Neuroscience

Cite this

Seye, C., Kong, Q., Yu, N., Gonzalez, F. A., Erb, L., & Weisman, G. A. (2007). P2 receptors in atherosclerosis and postangioplasty restenosis. Purinergic Signalling, 3(1-2), 153-162. https://doi.org/10.1007/s11302-006-9047-6

P2 receptors in atherosclerosis and postangioplasty restenosis. / Seye, Cheikh; Kong, Qiongman; Yu, Ningpu; Gonzalez, Fernando A.; Erb, Laurie; Weisman, Gary A.

In: Purinergic Signalling, Vol. 3, No. 1-2, 03.2007, p. 153-162.

Research output: Contribution to journalArticle

Seye, C, Kong, Q, Yu, N, Gonzalez, FA, Erb, L & Weisman, GA 2007, 'P2 receptors in atherosclerosis and postangioplasty restenosis', Purinergic Signalling, vol. 3, no. 1-2, pp. 153-162. https://doi.org/10.1007/s11302-006-9047-6
Seye, Cheikh ; Kong, Qiongman ; Yu, Ningpu ; Gonzalez, Fernando A. ; Erb, Laurie ; Weisman, Gary A. / P2 receptors in atherosclerosis and postangioplasty restenosis. In: Purinergic Signalling. 2007 ; Vol. 3, No. 1-2. pp. 153-162.
@article{5badbcc438e3438b92c7c593dd187e4e,
title = "P2 receptors in atherosclerosis and postangioplasty restenosis",
abstract = "Atherosclerosis is an immunoinflammatory process that involves complex interactions between the vessel wall and blood components and is thought to be initiated by endothelial dysfunction [Ross (Nature 362:801-809, 1993); Fuster et al. (N Engl J Med 326:242-250, 1992); Davies and Woolf (Br Heart J 69:S3-S11, 1993)]. Extracellular nucleotides that are released from a variety of arterial and blood cells [Di Virgilio and Solini (Br J Pharmacol 135:831-842, 2002)] can bind to P2 receptors and modulate proliferation and migration of smooth muscle cells (SMC), which are known to be involved in intimal hyperplasia that accompanies atherosclerosis and postangioplasty restenosis [Lafont et al. (Circ Res 76:996-1002, 1995)]. In addition, P2 receptors mediate many other functions including platelet aggregation, leukocyte adherence, and arterial vasomotricity. A direct pathological role of P2 receptors is reinforced by recent evidence showing that upregulation and activation of P2Y2 receptors in rabbit arteries mediates intimal hyperplasia [Seye et al. (Circulation 106:2720-2726, 2002)]. In addition, upregulation of functional P2Y receptors also has been demonstrated in the basilar artery of the rat double-hemorrhage model [Carpenter et al. (Stroke 32:516-522, 2001)] and in coronary artery of diabetic dyslipidemic pigs [Hill et al. (J Vasc Res 38:432-443, 2001)]. It has been proposed that upregulation of P2Y receptors may be a potential diagnostic indicator for the early stages of atherosclerosis [Elmaleh et al. (Proc Natl Acad Sci U S A 95:691-695, 1998)]. Therefore, particular effort must be made to understand the consequences of nucleotide release from cells in the cardiovascular system and the subsequent effects of P2 nucleotide receptor activation in blood vessels, which may reveal novel therapeutic strategies for atherosclerosis and restenosis after angioplasty.",
keywords = "Atherosclerosis, Inflammation, Migration, Nucleotide receptors, Proliferation, Restenosis, Smooth muscle cell",
author = "Cheikh Seye and Qiongman Kong and Ningpu Yu and Gonzalez, {Fernando A.} and Laurie Erb and Weisman, {Gary A.}",
year = "2007",
month = "3",
doi = "10.1007/s11302-006-9047-6",
language = "English (US)",
volume = "3",
pages = "153--162",
journal = "Purinergic Signalling",
issn = "1573-9538",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - P2 receptors in atherosclerosis and postangioplasty restenosis

AU - Seye, Cheikh

AU - Kong, Qiongman

AU - Yu, Ningpu

AU - Gonzalez, Fernando A.

AU - Erb, Laurie

AU - Weisman, Gary A.

PY - 2007/3

Y1 - 2007/3

N2 - Atherosclerosis is an immunoinflammatory process that involves complex interactions between the vessel wall and blood components and is thought to be initiated by endothelial dysfunction [Ross (Nature 362:801-809, 1993); Fuster et al. (N Engl J Med 326:242-250, 1992); Davies and Woolf (Br Heart J 69:S3-S11, 1993)]. Extracellular nucleotides that are released from a variety of arterial and blood cells [Di Virgilio and Solini (Br J Pharmacol 135:831-842, 2002)] can bind to P2 receptors and modulate proliferation and migration of smooth muscle cells (SMC), which are known to be involved in intimal hyperplasia that accompanies atherosclerosis and postangioplasty restenosis [Lafont et al. (Circ Res 76:996-1002, 1995)]. In addition, P2 receptors mediate many other functions including platelet aggregation, leukocyte adherence, and arterial vasomotricity. A direct pathological role of P2 receptors is reinforced by recent evidence showing that upregulation and activation of P2Y2 receptors in rabbit arteries mediates intimal hyperplasia [Seye et al. (Circulation 106:2720-2726, 2002)]. In addition, upregulation of functional P2Y receptors also has been demonstrated in the basilar artery of the rat double-hemorrhage model [Carpenter et al. (Stroke 32:516-522, 2001)] and in coronary artery of diabetic dyslipidemic pigs [Hill et al. (J Vasc Res 38:432-443, 2001)]. It has been proposed that upregulation of P2Y receptors may be a potential diagnostic indicator for the early stages of atherosclerosis [Elmaleh et al. (Proc Natl Acad Sci U S A 95:691-695, 1998)]. Therefore, particular effort must be made to understand the consequences of nucleotide release from cells in the cardiovascular system and the subsequent effects of P2 nucleotide receptor activation in blood vessels, which may reveal novel therapeutic strategies for atherosclerosis and restenosis after angioplasty.

AB - Atherosclerosis is an immunoinflammatory process that involves complex interactions between the vessel wall and blood components and is thought to be initiated by endothelial dysfunction [Ross (Nature 362:801-809, 1993); Fuster et al. (N Engl J Med 326:242-250, 1992); Davies and Woolf (Br Heart J 69:S3-S11, 1993)]. Extracellular nucleotides that are released from a variety of arterial and blood cells [Di Virgilio and Solini (Br J Pharmacol 135:831-842, 2002)] can bind to P2 receptors and modulate proliferation and migration of smooth muscle cells (SMC), which are known to be involved in intimal hyperplasia that accompanies atherosclerosis and postangioplasty restenosis [Lafont et al. (Circ Res 76:996-1002, 1995)]. In addition, P2 receptors mediate many other functions including platelet aggregation, leukocyte adherence, and arterial vasomotricity. A direct pathological role of P2 receptors is reinforced by recent evidence showing that upregulation and activation of P2Y2 receptors in rabbit arteries mediates intimal hyperplasia [Seye et al. (Circulation 106:2720-2726, 2002)]. In addition, upregulation of functional P2Y receptors also has been demonstrated in the basilar artery of the rat double-hemorrhage model [Carpenter et al. (Stroke 32:516-522, 2001)] and in coronary artery of diabetic dyslipidemic pigs [Hill et al. (J Vasc Res 38:432-443, 2001)]. It has been proposed that upregulation of P2Y receptors may be a potential diagnostic indicator for the early stages of atherosclerosis [Elmaleh et al. (Proc Natl Acad Sci U S A 95:691-695, 1998)]. Therefore, particular effort must be made to understand the consequences of nucleotide release from cells in the cardiovascular system and the subsequent effects of P2 nucleotide receptor activation in blood vessels, which may reveal novel therapeutic strategies for atherosclerosis and restenosis after angioplasty.

KW - Atherosclerosis

KW - Inflammation

KW - Migration

KW - Nucleotide receptors

KW - Proliferation

KW - Restenosis

KW - Smooth muscle cell

UR - http://www.scopus.com/inward/record.url?scp=33947625017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947625017&partnerID=8YFLogxK

U2 - 10.1007/s11302-006-9047-6

DO - 10.1007/s11302-006-9047-6

M3 - Article

C2 - 18404429

AN - SCOPUS:33947625017

VL - 3

SP - 153

EP - 162

JO - Purinergic Signalling

JF - Purinergic Signalling

SN - 1573-9538

IS - 1-2

ER -